The effect of Flaxseed Syrup on clinical manifestation of the pediatric asthma

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210801052048N1

Enrollment

Registered

2021-09-27

Start date

2021-10-02

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Mild persistent asthma, uncomplicated. Condition 2: Moderate persistent asthma, uncomplicated. Mild persistent asthma, uncomplicated Moderate persistent asthma, uncomplicated

Interventions

Intervention 1: Intervention group: Flaxseed syrup is prepared by boiling flaxseed in water and then adding honey until it reaches a suitable consistency and taste. Microbial preservatives are added a

Eligibility

Sex/Gender

All

Age

5 Years to 17 Years

Inclusion criteria

Inclusion criteria: Asthmatic patients between 5-17 years old referring to respiratory diseases clinic at Mofid children hospital, Tehran in 1400

Exclusion criteria

Exclusion criteria: unwillingness to participate in the study Suffering from severe asthma requiring hospitalization Suffering from other disease such as CF, BPD, heart failure, Tracheobronchomalacia, GERD, bronchiectasis, PTE and sarcoidosis Using ASA, beta blockers or NSAIDs Sensitivity to flaxseed and honey syrup components Suffering from acute asthma attack

Design outcomes

Primary

Measure	Time frame
Dyspnea based on ACT and CACT questionnaires, history and physical examination. Timepoint: Filling in ACT and CACT questionnaires at the beginning of the study and at the end of week 8, history and examination at the beginning of the study and at the end of weeks 4 and 8, telephone history at the end of weeks 2 and 6. Method of measurement: ACT and CACT questionnaires (Asthma Control Test & Children Asthma Control Test), visit of a pediatric specialist in respiratory diseases.;Wheezing based on ACT and CACT questionnaire and history or hearing examination. Timepoint: Filling in ACT and CACT questionnaires at the beginning of the study and at the end of week 8, history and examination at the beginning of the study and at the end of weeks 4 and 8, telephone history at the end of weeks 2 and 6. Method of measurement: ACT and CACT questionnaires (Asthma Control Test & Children Asthma Control Test), visit of a pediatric specialist in respiratory diseases.;Cough based on ACT and CACT questionnaires, history and physical examination. Timepoint: Filling in ACT and CACT questionnaires at the beginning of the study and at the end of week 8, history and examination at the beginning of the study and at the end of weeks 4 and 8, telephone history at the end of weeks 2 and 6. Method of measurement: ACT and CACT questionnaires (Asthma Control Test & Children Asthma Control Test), visit of a pediatric specialist in respiratory diseases.	—

Measure

Time frame

Dyspnea based on ACT and CACT questionnaires, history and physical examination. Timepoint: Filling in ACT and CACT questionnaires at the beginning of the study and at the end of week 8, history and examination at the beginning of the study and at the end of weeks 4 and 8, telephone history at the end of weeks 2 and 6. Method of measurement: ACT and CACT questionnaires (Asthma Control Test & Children Asthma Control Test), visit of a pediatric specialist in respiratory diseases.;Wheezing based on ACT and CACT questionnaire and history or hearing examination. Timepoint: Filling in ACT and CACT questionnaires at the beginning of the study and at the end of week 8, history and examination at the beginning of the study and at the end of weeks 4 and 8, telephone history at the end of weeks 2 and 6. Method of measurement: ACT and CACT questionnaires (Asthma Control Test & Children Asthma Control Test), visit of a pediatric specialist in respiratory diseases.;Cough based on ACT and CACT questionnaires, history and physical examination. Timepoint: Filling in ACT and CACT questionnaires at the beginning of the study and at the end of week 8, history and examination at the beginning of the study and at the end of weeks 4 and 8, telephone history at the end of weeks 2 and 6. Method of measurement: ACT and CACT questionnaires (Asthma Control Test & Children Asthma Control Test), visit of a pediatric specialist in respiratory diseases.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoroush Samari Kermani

Shahid Beheshti University of Medical Sciences

soroush.samari@sbmu.ac.ir+98 21 7746 7432

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026